Literature DB >> 19242795

Coronary artery disease in patients with liver cirrhosis.

Evangelos Kalaitzakis1, Annika Rosengren, Tomas Skommevik, Einar Björnsson.   

Abstract

BACKGROUND: The prevalence of coronary artery disease (CAD) has been reported to be low in patients with liver cirrhosis. Previous studies have, however, included mostly patients with cirrhosis due to hepatitis C. We aimed to determine the prevalence and predictive factors of CAD in a cohort of consecutive patients with cirrhosis of various etiologies compared to the general population.
METHODS: A total of 127 patients with cirrhosis were evaluated for a history of CAD and cardiovascular risk factors. Arterial blood pressure, fasting plasma glucose, and serum cholesterol were measured. Nutritional status was assessed by anthropometry and estimation of recent weight change. A group of 203 subjects from the general population with similar age and gender distribution, as well as smoking habits as the cirrhotic patients, served as controls.
RESULTS: CAD was more common in cirrhotics compared to controls (20% vs. 12%, P = 0.001). Compared to controls, cirrhotics had lower mean arterial blood pressure and serum cholesterol and a higher prevalence of diabetes, but did not differ significantly in the prevalence of hypertension or family history for CAD. In regression analysis, CAD was independently related to diabetes (odds ratio [OR] 5.47, 95% confidence interval [CI] 2.44-12.28), but not to liver cirrhosis. In the cirrhosis group, only alcoholic cirrhosis (OR 9.50, 95% CI 1.08-83.4) and age (OR 1.23 per year, 95% CI 1.06-1.43) were independently related to CAD.
CONCLUSIONS: Liver cirrhosis, per se, does not seem to confer a protective effect against CAD. In cirrhotics, older age and alcoholic etiology were independently related to CAD.

Entities:  

Mesh:

Year:  2009        PMID: 19242795     DOI: 10.1007/s10620-009-0738-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Arm anthropometry in a large reference population and in surgical patients.

Authors:  T Symreng
Journal:  Clin Nutr       Date:  1982-12       Impact factor: 7.324

2.  Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA.

Authors:  Christina M Berg; Lauren Lissner; Nibia Aires; Georgios Lappas; Kjell Torén; Lars Wilhelmsen; Annika Rosengren; Dag S Thelle
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-04

3.  Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis.

Authors:  Tsutomu Nishida; Shingo Tsuji; Masahiko Tsujii; Shoko Arimitsu; Yoshimichi Haruna; Eiichi Imano; Masaaki Suzuki; Tsutomu Kanda; Sunao Kawano; Naoki Hiramatsu; Norio Hayashi; Masatsugu Hori
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

4.  Trends in overweight and obesity from 1985 to 2002 in Göteborg, West Sweden.

Authors:  C Berg; A Rosengren; N Aires; G Lappas; K Torén; D Thelle; L Lissner
Journal:  Int J Obes (Lond)       Date:  2005-08       Impact factor: 5.095

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation.

Authors:  J S Plotkin; R M Benitez; P C Kuo; M J Njoku; L A Ridge; J W Lim; C D Howell; J M Laurin; L B Johnson
Journal:  Liver Transpl Surg       Date:  1998-07

Review 9.  Nutrition and chronic liver disease.

Authors:  Carla Matos; Michael K Porayko; Nickie Francisco-Ziller; Sara DiCecco
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062

10.  Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.

Authors:  C L Donovan; P A Marcovitz; J D Punch; D S Bach; K A Brown; M R Lucey; W F Armstrong
Journal:  Transplantation       Date:  1996-04-27       Impact factor: 4.939

View more
  23 in total

Review 1.  Renal impairment in cirrhosis unrelated to hepatorenal syndrome.

Authors:  Gavin Low; Graeme Jm Alexander; David J Lomas
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

2.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

3.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

4.  The relationship between coronary artery disease and cardiovascular events early after liver transplantation.

Authors:  Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui
Journal:  Liver Int       Date:  2019-03-26       Impact factor: 5.828

Review 5.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

Review 6.  Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Sehrish Kamal; Muhammad Ali Khan; Ankur Seth; George Cholankeril; Deepansh Gupta; Utkarsh Singh; Faisal Kamal; Colin W Howden; Christopher Stave; Satheesh Nair; Sanjaya K Satapathy; Aijaz Ahmed
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

7.  Study on assessment of renal function in chronic liver disease.

Authors:  Nupur Das; Agnihotri Bhattacharyya; Baishakhi Paria; Sujoy Sarkar
Journal:  J Clin Diagn Res       Date:  2015-03-01

8.  SPECT myocardial perfusion imaging in liver transplantation candidates.

Authors:  W Lane Duvall; Aditi Singhvi; Nidhi Tripathi; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2018-08-23       Impact factor: 5.952

9.  Statin use in patients with cirrhosis: a retrospective cohort study.

Authors:  Sonal Kumar; Norman D Grace; Amir A Qamar
Journal:  Dig Dis Sci       Date:  2014-05-18       Impact factor: 3.199

Review 10.  Kidneys in chronic liver diseases.

Authors:  Marek Hartleb; Krzysztof Gutkowski
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.